Clinical White Papers and Case Studies
-
Case Study: Global Oncology
2/1/2024
Scout's transportation, expense reimbursement, and time and wage loss compensation helped an oncology study recruit and retain hard-to-reach patients.
-
Navigating Sensitive Country Requirements
2/1/2024
See how Scout expertly navigated complex regional laws and regulations to allow study patients in Iran access to treatment in Turkey.
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
1/24/2024
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
Discovering Excellence In Ophthalmic Trials
1/19/2024
Understand why efficient ePRO solutions are essential in measuring patients' perception of their symptoms and quality of life in ophthalmology research.
-
What You Need To Run Your Pediatric Asthma Clinical Trials Successfully
1/19/2024
Discover the essential elements for running asthma clinical trials. With several unique specifications to consider, it's crucial to understand the key factors that lead to success.
-
Operationalizing Disclosure Intelligence For Compliance At Scale
1/19/2024
Learn how sponsors can transform compliance functions into unique strengths, not only meeting regulatory requirements but also uncovering strategic opportunities in this challenging landscape.
-
Transforming Invoice And Payment Processes While Reducing Costs
1/18/2024
Uncover how Uni Hospital, a state-of-the-art medical center in Bulgaria was able to process invoices and receive payments quicker while noticeably improving accuracy.
-
What Does The New FDA DHT Guidance Mean?
1/18/2024
In December 2023, the FDA released the final version of its digital health technologies guidance, outlining the facilitated use of sensor-based DHTs and wearables in clinical investigations.
-
Unified Platform Supports Rapid Implementation Of Rescue Study
1/17/2024
Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.
-
eSource For A COVID Treatment Trial
1/17/2024
Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.